Best Value Stocks To Own Right Now


Michael A. Robinson

I’ve recently been thinking a lot about the day the stock market crashed in October 1987.

You know why…

On Oct. 19, 1987 – Black Monday – the Dow Jones Industrial Average lost 22.6% of its value in a single day.

And ever since Jan. 26, we’ve seen the Dow drop 10%, regain half of that, and then drop and bounce back some again and again.

Back in 1987, I was a banking and technology analyst working in San Francisco’s financial district. My boss called me from New York after the market closed on Black Monday to talk it over.

Best Value Stocks To Own Right Now: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PNC Financial Services Group Inc. increased its holdings in Arrow Electronics, Inc. (NYSE:ARW) by 29.7% in the first quarter, HoldingsChannel.com reports. The firm owned 19,225 shares of the technology company’s stock after buying an additional 4,405 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Arrow Electronics were worth $1,480,000 at the end of the most recent reporting period.

  • [By Lee Jackson]

    This award-winning company looks poised to come in strong for the quarter. Arrow Electronics Inc. (NYSE: ARW) is a worldwide provider of products, services and solutions to industrial and commercial users of electronic components and enterprise computing solutions.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Arrow Electronics (ARW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Arrow Electronics (NYSE:ARW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Arrow Electronics reported better-than-expected results for first-quarter 2018. The figures also came above the mid-point of the company’s guidance ranges and marked year-over-year improvement. Moreover, the electronic component distributor provided an optimistic guidance for second-quarter 2018. We believe that the company’s core strength in providing best-in-class services and easy-to-acquire technologies should drive growth in the long run. Moreover, the company has secured a significant market share through a broad portfolio of products and services, and continued efforts to maximize consumer satisfaction. Additionally, incremental sales from strategic acquisitions and partnerships are expected to boost the top line. However, an uncertain economic environment, high debt burden and competition remain the concerns. Notably, the stock has outperformed the industry in the last one year.”

Best Value Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Shane Hupp]

    News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Best Value Stocks To Own Right Now: NeuroMetrix Inc.(NURO)


Advisors’ Opinion:

  • [By Shane Hupp]

    Haemonetics (NYSE: HAE) and Neurometrix (NASDAQ:NURO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.

  • [By Logan Wallace]

    Obalon Therapeutics (NASDAQ: OBLN) and Neurometrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability.

Best Value Stocks To Own Right Now: First Citizens BancShares, Inc.(FCNCA)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

Best Value Stocks To Own Right Now: Masimo Corporation(MASI)


Advisors’ Opinion:

  • [By Motley Fool Staff]

    So while Fischer is pitching cloud software company AppFolio (NASDAQ:APPF)and Bush suggests cybersecurity player Carbon Black(NASDAQ:CBLK), Moser is going with a healthcare basket: insurer UnitedHealth Group(NYSE:UNH) big dog, medical device maker Masimo(NASDAQ:MASI), pet-focused Idexx Labs(NASDAQ:IDXX), and remote medicine leader Teladoc(NYSE:TDOC).

  • [By VantagePoint]

    Masimo Corporation (NASDAQ: MASI) had a predictive moving average crossover to the upside in early-April indicating a bullish trend. As soon as the blue line crossed above the black line, VantagePoint users knew they should start taking long positions in this market. The Neural Index also supported that move to the upside. In 18 trading days, $MASI was up almost 14 percent or $11.77 per share.

  • [By Max Byerly]

    Masimo Co. (NASDAQ:MASI) Director Steven Barker sold 10,000 shares of the stock in a transaction on Wednesday, May 30th. The stock was sold at an average price of $100.00, for a total value of $1,000,000.00. Following the completion of the transaction, the director now directly owns 73,249 shares of the company’s stock, valued at approximately $7,324,900. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Leave a Reply

Your email address will not be published.